Valeant Pharmaceuticals International of Canada
-
Valeant to Buy Bausch & Lomb for $8.7 Billion
[THE NEW YORK TIMES] Bausch & Lomb, the eye care company, agreed on Monday to sell itself to Valeant Pharmaceuticals International of…
Read More »